Oncorus, Inc.
ONCRDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671818
Oncorus, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Dec 30, 2022; 32 institutions reported holding it in 13F filings for Q1 2023, worth $3.78M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Oncorus, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ONCR is no longer listed, so this page shows Q1 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 32
- −1 vs. Q4 2022
- Shares held
- 11.0M
- −4.62M (−29.6%) vs. Q4 2022
- Total value
- $3.78M
- −$173.1K (−4.4%) vs. Q4 2022
- New holders
- 3
- 3 more added
- Sold out
- 4
- 13 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ONCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 1 | $3 |
| Q2 2023 | 4 | $212.1K |
| Q1 2023 | 32 | $3.78M |
| Q4 2022 | 33 | $3.95M |
| Q3 2022 | 40 | $14.1M |
| Q2 2022 | 45 | $21.4M |
| Q1 2022 | 56 | $34.5M |
| Q4 2021 | 56 | $107.1M |
| Q3 2021 | 48 | $186.2M |
| Q2 2021 | 50 | $282.6M |
| Q1 2021 | 57 | $278.2M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Oncorus, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 353 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 225 | $0 | 0.00% | −3−1.3% | Reduced |
| Your Advocates Ltd., LLP | 100 | $34 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 100 | $35 | 0.00% | +100 | New |
| Wells Fargo & Company | 135 | $46 | 0.00% | +2+1.5% | Added |
| Bank of America Corp | 823 | $283 | 0.00% | −43,965−98.2% | Reduced |
| Morgan Stanley | 4,506 | $1.55K | 0.00% | −3,888−46.3% | Reduced |
| Tower Research Capital LLC (TRC) | 8,581 | $3.00K | 0.00% | −21−0.2% | Reduced |
| Barclays PLC | 9,495 | $3.27K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 10,195 | $3.51K | 0.00% | −6,994−40.7% | Reduced |
| UBS Group AG | 14,650 | $5.04K | 0.00% | +14,650 | New |
| Susquehanna International Group, LLP | 17,525 | $6.03K | 0.00% | +17,525 | New |
| HSBC Holdings PLC | 26,452 | $8.73K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 25,999 | $8.95K | 0.00% | −1,898,423−98.6% | Reduced |
| Northern Trust Corp | 28,525 | $9.82K | 0.00% | −435−1.5% | Reduced |
| Two Sigma Investments, LP | 51,680 | $17.8K | 0.00% | −11,112−17.7% | Reduced |
| Bank of New York Mellon Corp | 66,498 | $22.9K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 67,300 | $23.2K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 70,135 | $24.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 75,712 | $26.1K | 0.00% | −23,488−23.7% | Reduced |
| We Are One Seven, LLC | 116,354 | $40.0K | 0.00% | 00.0% | Unchanged |
| SG Americas Securities, LLC | 126,525 | $44.0K | 0.00% | +53,833+74.1% | Added |
| Geode Capital Management, LLC | 135,751 | $46.7K | 0.00% | −2,176−1.6% | Reduced |
| BlackRock Inc. | 139,040 | $47.8K | 0.00% | −632−0.5% | Reduced |
| Renaissance Technologies LLC | 144,000 | $50.0K | 0.00% | −142,936−49.8% | Reduced |
| Millennium Management LLC | 286,667 | $99.0K | 0.00% | +10,309+3.7% | Added |
| Vanguard Group Inc | 475,345 | $163.6K | 0.00% | −20,568−4.1% | Reduced |
| Sphera Funds Management Ltd. | 540,258 | $185.9K | 0.04% | 00.0% | Unchanged |
| Fosun International Ltd | 962,323 | $327.2K | 0.03% | 00.0% | Unchanged |
| CHI Advisors LLC | 2,367,436 | $814.6K | 0.22% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 2,377,031 | $817.7K | 0.21% | 00.0% | Unchanged |
| MPM Asset Management LLC | 2,849,464 | $980.2K | 0.41% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −2,536,186−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −14,707−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,972−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −506−100.0% | Sold out |